Post by Regeneron on X
Regeneron@Regeneron
XThe FDA granted accelerated approval for our medicine to treat relapsed/refractory #multiplemyeloma after at least four prior lines of therapy. This milestone reflects our relentless commitment to make a meaningful impact in the lives of people living with multiple myeloma.
56 likes3 repliesPosted Jul 2, 2025